Becton DickinsonBDXEarnings & Financial Report
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.
BDX Q1 2026 Key Financial Metrics
营收
$5.3B
毛利润
$2.4B
营业利润
$552.0M
净利润
$382.0M
毛利率
45.9%
营业利润率
10.5%
净利率
7.3%
同比增长
-0.4%
EPS
$1.34
资金流向
Becton Dickinson Q1 2026 Financial Summary
Becton Dickinson reported revenue of $5.3B for Q1 2026, with a net profit of $382.0M (7.3% margin). Cost of goods sold was $2.8B, operating expenses totaled $1.9B.
Key Financial Metrics
| Total Revenue | $5.3B |
|---|---|
| Net Profit | $382.0M |
| Gross Margin | 45.9% |
| Operating Margin | 10.5% |
| Report Period | Q1 2026 |
Becton Dickinson Annual Revenue by Year
Becton Dickinson annual revenue history includes year-by-year totals (for example, 2025 revenue was $21.5B).
| Year | Annual Revenue |
|---|---|
| 2025 | $21.5B |
| 2024 | $20.2B |
| 2023 | $19.3B |
| 2022 | $18.9B |
利润表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $4.99B | $4.99B | $5.17B | $5.27B | $5.51B | $5.51B | $5.25B | $5.25B |
| 同比增长 | 2.3% | 2.3% | 9.8% | 4.5% | 10.4% | 10.4% | 1.6% | -0.4% |
资产负债表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $55.58B | $57.29B | $54.66B | $54.47B | $54.90B | $55.33B | $54.84B | $54.84B |
| 总负债 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 股东权益 | $25.87B | $25.89B | $25.20B | $25.24B | $25.47B | $25.39B | $25.28B | $25.28B |
现金流量表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $1.30B | $1.18B | $693.0M | $164.0M | $1.22B | $1.35B | $657.0M | $657.0M |
Other Health Care Companies
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
BAX
Baxter International
营收
$3.0B
净利润
$-1.1B
BSX
Boston Scientific
营收
$5.3B
净利润
$670.0M
DXCM
Dexcom
营收
$1.3B
净利润
$267.3M
EW
Edwards Lifesciences
营收
$1.6B
净利润
$291.1M
GEHC
GE HealthCare
营收
$5.7B
净利润
$588.0M
HOLX
Hologic
营收
$1.0B
净利润
$179.1M
IDXX
Idexx Laboratories
营收
$1.1B
净利润
$274.6M
PODD
Insulet Corporation
营收
$783.7M
净利润
$101.6M
ISRG
Intuitive Surgical
营收
$2.9B
净利润
$794.8M